Eris Lifesciences operates as a prominent specialty pharmaceutical company focused on branded generics within the Indian domestic market, particularly targeting chronic therapeutic categories like cardiovascular, anti-diabetes, and CNS therapies. Its main industry competitors include large-scale Indian pharmaceutical corporations such as Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, Lupin, Torrent Pharmaceuticals, and Alkem Laboratories, all of which maintain extensive portfolios and powerful field forces targeting medical practitioners across India.